Stay updated with breaking news from Nasdaq Amph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Michael A. Zasloff sold 7,500 shares of Amphastar Pharmaceuticals stock in a transaction dated Monday, May 15th. The shares were sold at an average price of $42.18, for a total transaction of $316,350.00. Following the completion of the transaction, the director now directly owns 43,869 shares of […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Richard K. Prins sold 5,000 shares of the stock in a transaction on Friday, May 12th. The stock was sold at an average price of $42.06, for a total value of $210,300.00. Following the sale, the director now owns 47,342 shares in the company, valued at approximately […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating)’s share price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $44.78 and last traded at $44.57, with a volume of 178928 shares changing hands. The stock had previously closed at $42.97. Wall Street Analyst Weigh In Separately, StockNews.com assumed […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Michael A. Zasloff sold 7,500 shares of the firm’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $42.18, for a total value of $316,350.00. Following the transaction, the director now owns 43,869 shares in the company, valued at […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Richard K. Prins sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $42.06, for a total transaction of $210,300.00. Following the completion of the transaction, the director now directly owns 47,342 […]